Advancing Drug Development: FDA’s Take on In Silico Trials Posted on August 12, 2024May 6, 2025 by Hannah Faulkner
Advancing Drug Development: FDA’s Take on In Silico Trials Posted on August 12, 2024May 1, 2025 by Hannah Faulkner Advancing Drug Development: FDA’s Take on In Silico Trials
FDA and CTTI Hold Joint Workshop on AI in Drug Development – AI: The Washington Report Posted on August 9, 2024May 6, 2025 by Hannah Faulkner FDA and CTTI Hold Joint Workshop on AI in Drug Development – AI: The Washington Report
Equity in Action: Data-Driven Strategies to Advance Diversity in Clinical Trials Posted on July 17, 2024May 6, 2025 by Hannah Faulkner Equity in Action: Data-Driven Strategies to Advance Diversity in Clinical Trials
Reservations, Great Plains and rural counties ripe for decentralized trials: Milken report Posted on July 2, 2024May 6, 2025 by Hannah Faulkner Reservations, Great Plains and Rural Counties Ripe for Decentralized Trials: Milken Report
Exploring 5 Types of Clinical Trial Data Sharing Platforms Posted on May 28, 2024May 6, 2025 by Hannah Faulkner Exploring 5 types of clinical trial data sharing platforms
ICER Debuts Clinical Trial Diversity Assessment Framework Posted on May 3, 2024May 6, 2025 by Hannah Faulkner ICER Debuts Clinical Trial Diversity Assessment Framework
Clinical Trials Transformation Initiative’s (CTTI) Vision for Clinical Trials by 2030 Posted on April 24, 2024May 6, 2025 by Hannah Faulkner
Clinical Trials Transformation Initiative’s (CTTI) Vision for Clinical Trials by 2030 Posted on April 24, 2024April 25, 2024 by Hannah Faulkner Clinical Trials Transformation Initiative’s (CTTI) Vision for Clinical Trials by 2030
Forum on Drug Discovery, Development, and Translation 2023 Annual Review Posted on March 21, 2024 by Hannah Faulkner Forum on Drug Discovery, Development, and Translation 2023 Annual Review
